Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
135.02
-13.32 (-8.98%)
At close: Feb 27, 2026, 4:00 PM EST
133.16
-1.86 (-1.38%)
After-hours: Feb 27, 2026, 7:07 PM EST
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.81 billion as of February 27, 2026. Its market cap has increased by 901.08% in one year.
Market Cap
1.81B
Enterprise Value
1.77B
1-Year Change
901.08%
Ranking
Category
Stock Price
$135.02
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.81B, an increase of 1,160.13%. That is a compound annual growth rate of 730.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 1.99B | 60.88% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.50B |
| uniQure | 1.50B |
| Monte Rosa Therapeutics | 1.49B |
| Trevi Therapeutics | 1.49B |
| Capricor Therapeutics | 1.48B |
| EyePoint | 1.46B |
| Savara | 1.45B |
| Septerna | 1.44B |